Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclomethasone dipropionate versus prednisone in active ulcerative colitis
2006-004230-32Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Sep 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in autoimmune colitis comparing Beclomethasone dipropionate with Prednisone (2 arms). Primary endpoints: Clinical response at week 4, Steroid safety profile at week 4 and 1 more. Started Sep 2007; status: completed.
02
Drugs
beclomethasone dipropionateprednisone
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2006-004230-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004230-32.